Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis.
about
Chronic lymphocytic leukemia radiogenicity: a systematic reviewIonizing radiation and chronic lymphocytic leukemia.Mouse models for radiation-induced cancersMouse models for efficacy testing of agents against radiation carcinogenesis—a literature reviewEpidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelinesRadiation-induced signaling results in mitochondrial impairment in mouse heart at 4 weeks after exposure to X-raysDose-responses from multi-model inference for the non-cancer disease mortality of atomic bomb survivorsReview and meta-analysis of epidemiological associations between low/moderate doses of ionizing radiation and circulatory disease risks, and their possible mechanismsDo non-targeted effects increase or decrease low dose risk in relation to the linear-non-threshold (LNT) model?Risk of non-Hodgkin lymphoma after radiotherapy for solid cancersRisk factors for acute leukemia in children: a reviewOn the use of combinatorial antibody libraries to clone the "fossil record" of an individual's immune responseRadiation and Circulatory DiseaseRadiotherapy for benign disease; assessing the risk of radiation-induced cancer following exposure to intermediate dose radiation.Ankylosing spondylitis and monoclonal gammopathies.Insights from radiation treatment for benign disease.Using mortality data to estimate radiation effects on breast cancer incidence.Risk of benzene-induced leukemia predicted from the Pliofilm cohort.Histologic verification of leukemia, myelodysplasia, and multiple myeloma diagnoses in patients in Ukraine, 1987-1998.Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant miceRadon exposure and cancers other than lung cancer in Swedish iron minersDiagnostic radiography and adult acute myeloid leukaemia: an interview and medical chart review study.Cancer risk assessment and prevention: where do we stand?A model for dose rate and duration of exposure effects in radiation carcinogenesisIron, radiation, and cancerHormesis, an update of the present position.12. Cancers in 2010 attributable to ionising radiation exposure in the UK.Striking a balance: benefit and risk in man's exposure to man-made radiations.Current concepts on monoclonal gammopathies.Trends in childhood leukaemia in the Nordic countries in relation to fallout from atmospheric nuclear weapons testing.Establishing the possible radiogenicity of morbidity and mortality from participation in UK nuclear weapons development.A case/control study of adult haematological malignancies in relation to overhead powerlines.Analysis of dose response for circulatory disease after radiotherapy for benign disease.Childhood leukaemia in Europe after Chernobyl: 5 year follow-upA summary of mortality and incidence of cancer in men from the United Kingdom who participated in the United Kingdom's atmospheric nuclear weapon tests and experimental programmesSubsequent primary cancers in relation to treatment of ovarian cancer.Can prophylactic breast irradiation contribute to cardiac toxicity in patients with prostate cancer receiving androgen suppressing drugs?Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model.Atherosclerosis and endothelial dysfunction in patients with ankylosing spondylitis.Cardiac side effects of conventional and particle radiotherapy in cancer patients.
P2860
Q23921281-7796B0DB-5455-4422-BA8C-CBFFD664F9F7Q24534890-4B8A3567-57D9-44C4-8C97-96DB197E4244Q26747129-54CAAC60-F378-4F89-9B8B-F0319AC9E3AAQ26999068-9B16CF27-2BB1-473E-BD90-7D3D881CCFC8Q27023830-6DED7C5A-60A0-44A6-86EC-D3FEE231FE5FQ27676239-2CDE89DA-D377-4D9E-81E8-17E01CFD2C0FQ28383681-825C1916-6B83-41EF-898D-E577FB2C8A9FQ28387812-3B556494-0681-47A3-B7C8-1DD522DE7DCDQ28387928-77BB1DDB-8B8B-44C4-98D9-9E1BBCF12F77Q28392833-9981AC01-00B4-4B48-B396-02F57F6FBB17Q28763258-74A7884B-26B8-4F65-8ED8-D2D5B7E72D7EQ28775795-0643D0B8-B953-4E60-B63F-B594A87DFA4DQ29248999-87464C4E-4849-4338-AC43-666CC04BF42DQ30368547-AE529D54-9B63-4574-8F09-80E9C9FC4BB7Q33564944-34F67A3D-CCC2-4582-82DD-ED63B60A5145Q34071665-1CCE8845-4D29-4CCA-883A-4C140F8E9A47Q34301671-DC481537-8945-44DD-8FD4-657685E87688Q34637511-0F3FBC70-07F8-445E-8DDC-CE42E21A88ACQ34759821-9AA55DA2-AC5F-4298-AB4E-1950994489B5Q34799331-C77B219D-D561-4AAA-B7F0-724352929B9EQ34831368-D833E604-40F1-47D8-97CC-DFB34A16A5A8Q35006886-57A2DC12-27B0-4E9E-8BA8-CF9417D127EEQ35032630-77E474B3-590C-4E8D-A017-87C8762E4140Q35033526-42200AF7-2BB9-4D47-83C2-04B96B961A4EQ35033580-404655CE-6A01-40A5-8C59-DF82C20F840AQ35116770-90F1419E-5B42-41C9-9771-FD7CEA54F525Q35654781-3E87A4F7-8024-4D5C-A25D-6E7CB5023506Q35660083-26A07DF9-D245-44C1-97F8-6C5F68F9B9CFQ35671881-CEC51EA5-9A26-4D2B-B7E8-73A2214F38A5Q35820976-353EE9E6-41D7-47F5-BF89-97E0CB840D27Q35929654-7DEA436A-5821-4B5D-A836-C6B2F33495D0Q35984752-830B878E-B75E-401C-ABC3-35079BAFF734Q36094942-972EFA47-F76D-4A83-B5CE-7DEEA135A621Q36138659-46EFF1F4-F5AB-4FE3-9061-E12FC3518FD8Q36432998-EB8FFF37-2D67-4DAC-B341-906C5B69EF81Q36467375-573FCD65-3219-4CE5-8549-6C44F2E96C54Q36473630-8283C036-2D84-476B-AA4B-129101898BEBQ37174844-EC3E2830-9634-4167-899F-615CA667A233Q37720424-C533F839-B6CF-478C-89F4-D4D6B50C75D5Q37883959-99B4E7EC-A9C3-4D94-BF6A-05F4583250EB
P2860
Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Long term mortality after a si ...... ed for ankylosing spondylitis.
@ast
Long term mortality after a si ...... ed for ankylosing spondylitis.
@en
type
label
Long term mortality after a si ...... ed for ankylosing spondylitis.
@ast
Long term mortality after a si ...... ed for ankylosing spondylitis.
@en
prefLabel
Long term mortality after a si ...... ed for ankylosing spondylitis.
@ast
Long term mortality after a si ...... ed for ankylosing spondylitis.
@en
P2093
P2860
P356
P1476
Long term mortality after a si ...... ed for ankylosing spondylitis.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1987.35
P407
P577
1987-02-01T00:00:00Z